Cargando…
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230841/ https://www.ncbi.nlm.nih.gov/pubmed/34182049 http://dx.doi.org/10.1053/j.ajkd.2021.06.004 |
_version_ | 1783713305126240256 |
---|---|
author | Bomback, Andrew S. Kudose, Satoru D’Agati, Vivette D. |
author_facet | Bomback, Andrew S. Kudose, Satoru D’Agati, Vivette D. |
author_sort | Bomback, Andrew S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8230841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | by the National Kidney Foundation, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82308412021-06-28 De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? Bomback, Andrew S. Kudose, Satoru D’Agati, Vivette D. Am J Kidney Dis Editorial by the National Kidney Foundation, Inc. 2021-10 2021-06-25 /pmc/articles/PMC8230841/ /pubmed/34182049 http://dx.doi.org/10.1053/j.ajkd.2021.06.004 Text en © 2021 by the National Kidney Foundation, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Bomback, Andrew S. Kudose, Satoru D’Agati, Vivette D. De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title | De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title_full | De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title_fullStr | De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title_full_unstemmed | De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title_short | De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far? |
title_sort | de novo and relapsing glomerular diseases after covid-19 vaccination: what do we know so far? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230841/ https://www.ncbi.nlm.nih.gov/pubmed/34182049 http://dx.doi.org/10.1053/j.ajkd.2021.06.004 |
work_keys_str_mv | AT bombackandrews denovoandrelapsingglomerulardiseasesaftercovid19vaccinationwhatdoweknowsofar AT kudosesatoru denovoandrelapsingglomerulardiseasesaftercovid19vaccinationwhatdoweknowsofar AT dagativivetted denovoandrelapsingglomerulardiseasesaftercovid19vaccinationwhatdoweknowsofar |